Exponent stock fell 3.72 percent on October 2

Published on 10/04/2026 at 22:32 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

Exponent stock's Q2 net revenue rose 12 percent year over year to USD 148.9 million. Operating results and analyst targets frame the next valuation test.

EXPO, US30214U1025, Illustration mit AI erstellt.

Exponent (ISIN US30214U1025) was last at USD 67.30 on Nasdaq on October 2, 2026, down USD 2.60 or 3.72 percent from the prior close of USD 69.90. The move leaves the engineering and scientific consulting company between its 52-week low of USD 51.91 and high of USD 81.95 as investors weigh strong quarterly growth against a premium valuation.

Q2 revenue rose 12 percent

The most recent operating figures came from Exponent's second quarter of fiscal year 2026, ended July 3, 2026. According to the Yahoo Finance transcript, total revenue increased 21 percent year over year to USD 171.6 million, while net revenue rose 12 percent to USD 148.9 million.

The earnings quality also improved on several measures. Q2 net income increased 11 percent to USD 29.4 million from USD 26.6 million, diluted EPS rose 15 percent to USD 0.60 from USD 0.52, and EBITDA increased 16 percent to USD 42.7 million. EBITDA margin reached 28.7 percent of net revenue, compared with 27.8 percent in Q2 2025, according to the same Yahoo Finance transcript.

AI work supports demand

Exponent's management linked the quarter's demand to user research for AI-enabled products, utility-sector risk management and dispute-related consulting. The transcript also described rising work around autonomous vehicles, data centers, battery storage and power infrastructure, giving the growth story several operating channels rather than a single technology exposure.

The quarter included a large user research study that represented 4 percent of net revenue, compared with 2 percent expected for the project. That concentration matters because it lifted utilization and revenue in Q2, while the broader consulting model still depends on continued project demand across technology, transportation, utilities and regulated industries.

Analysts set targets above USD 67.30

MarketBeat reported a Moderate Buy consensus from four analysts with an average price target of USD 81.00. Against the USD 67.30 Nasdaq price on October 2, 2026, that target lies 20.4 percent above the price, according to MarketBeat.

The individual views show a wider spread around that average. JPMorgan raised its price objective from USD 80.00 to USD 90.00 and assigned an Overweight rating, while UBS set a USD 72.00 target with a Neutral rating in reports dated July 31, 2026, as MarketBeat reported.

Stock stays below yearly high

Exponent stock was last at USD 67.30 on Nasdaq on October 2, 2026, with a market capitalization of USD 3.3 billion and volume of 582,171 shares; its 52-week range was USD 51.91 to USD 81.95.